108 related articles for article (PubMed ID: 27916718)
1. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
[TBL] [Abstract][Full Text] [Related]
2. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
[TBL] [Abstract][Full Text] [Related]
3. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
[TBL] [Abstract][Full Text] [Related]
5. Opa interacting protein 5 acts as an oncogene in bladder cancer.
He X; Hou J; Ping J; Wen D; He J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
[TBL] [Abstract][Full Text] [Related]
6. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C
Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485
[TBL] [Abstract][Full Text] [Related]
8. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
[TBL] [Abstract][Full Text] [Related]
10. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
[TBL] [Abstract][Full Text] [Related]
11. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
12. Opa-Interacting Protein 5 Expression in Human Glioma Tissues Is Essential to the Biological Function of U251 Human Malignant Glioma Cells.
Chen L; Wang R; Gao L; Shi W
Cancer Control; 2020; 27(1):1073274820968914. PubMed ID: 33153318
[TBL] [Abstract][Full Text] [Related]
13. OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers.
Chun HK; Chung KS; Kim HC; Kang JE; Kang MA; Kim JT; Choi EH; Jung KE; Kim MH; Song EY; Kim SY; Won M; Lee HG
BMB Rep; 2010 May; 43(5):349-54. PubMed ID: 20510019
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.
He X; Ding X; Wen D; Hou J; Ping J; He J
Pathol Res Pract; 2017 Sep; 213(9):1059-1066. PubMed ID: 28843748
[TBL] [Abstract][Full Text] [Related]
15. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR.
Kim J; Abdelmohsen K; Yang X; De S; Grammatikakis I; Noh JH; Gorospe M
Nucleic Acids Res; 2016 Mar; 44(5):2378-92. PubMed ID: 26819413
[TBL] [Abstract][Full Text] [Related]
16. miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype.
Tommasi S; Pinto R; Danza K; Pilato B; Palumbo O; Micale L; De Summa S
Oncotarget; 2016 Dec; 7(49):80363-80372. PubMed ID: 27385001
[TBL] [Abstract][Full Text] [Related]
17. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis.
Wang H; Xiao Y; Wu L; Ma D
Int J Oncol; 2018 Mar; 52(3):743-754. PubMed ID: 29431182
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway.
Hu GW; Wu L; Kuang W; Chen Y; Zhu XG; Guo H; Lang HL
Gene; 2017 Apr; 610():24-31. PubMed ID: 28189759
[TBL] [Abstract][Full Text] [Related]
20. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
